BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ku0063794

an mTOR inhibitor; structure in first source

7+ PubMed studies analyzed · Evidence Score: 27.3

Research Domains

Ku0063794 has been studied across 7 research domains including 🔬 Oncology, 🏋️ Muscle & Hypertrophy, 🛡️ Immunity, ⏳ Longevity & Aging, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 71% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ku0063794, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

torin
12 shared targets
alpelisib
7 shared targets
Puromycin
6 shared targets
Thapsigargin
7 shared targets
monorden
6 shared targets
Deslanoside
6 shared targets
Fluvastatin
4 shared targets
withaferin
6 shared targets
Decitabine
5 shared targets
Canagliflozin
4 shared targets
Loading evidence profile...

This evidence profile for Ku0063794 is generated deterministically from 7 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.